Evidence map›Paper›PMID 35577664›Full record

ArticleJournal of substance abuse treatment2022

Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.

Nadia Tabatabaeepour, Jake R Morgan, Ali Jalali, Shashi N Kapadia, Angélica Meinhofer

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Association between medication for opioid use disorder during pregnancy and neonatal outcomes.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.Expert review of pharmacoeconomics & outcomes research · 2024
    Review
  12. Article
  13. Overdoses, Reproductive Justice, and Harm Reduction.American journal of public health · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nadia TabatabaeepourDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
Jake R MorganDepartment of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, United States.
Ali JalaliDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
Shashi N KapadiaDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States.
Angélica MeinhoferDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY, United States. Electronic address: anm4001@med.cornell.edu.
Cornell University · USBoston University · USWeill Cornell Medicine · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Yuhua Bao · 2015 to 2026
$20.7M
Researching Effective Strategies to Prevent Opioid Death (RESPOND)R01DA046527 · NIDA · BOSTON MEDICAL CENTER · PI Benjamin P. Linas · 2018 to 2026
$7.2M
Improving Naloxone Access and Its Effects on Drug Abuse and OverdosesR01CE002999 · CE · RAND CORPORATION · PI POWELL, DAVID · 2018 to 2020
$1.9M
Intergenerational effects of America's opioid crisis: Parental drug use and offspring healthK01DA051777 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI MEINHOFER, ANGELICA · 2020 to 2025
$974k
Integrated Care for Hepatitis C: Current Uptake & Impact on Future TreatmentK01DA048172 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI KAPADIA, SHASHI · 2019 to 2023
$948k
ACL HHS R01CE002999NCIPC CDC HHS R01 CE002999NIAID NIH HHS P30 AI042853NIDA NIH HHS K01 DA048172NIDA NIH HHS K01 DA051777NIDA NIH HHS P30 DA040500NIDA NIH HHS R01 DA046527
6 · The paper itself

Abstract

introductionStates' approaches to addressing prenatal substance use are widely heterogeneous, ranging from supportive policies that enhance access to substance use disorder (SUD) treatment to punitive policies that criminalize prenatal substance use. We studied the effect of these prenatal substance use policies (PSUPs) on medications for opioid use disorder (OUD) treatment, including buprenorphine, naltrexone, and methadone, psychosocial services for SUD treatment, opioid prescriptions, and opioid overdoses among commercially insured pregnant females with OUD. We evaluated: (1) punitive PSUPs criminalizing prenatal substance use or defining it as child maltreatment; (2) supportive PSUPs granting pregnant females priority access to SUD treatment; and (3) supportive PSUPs funding targeted SUD treatment programs for pregnant females.

methodsWe analyzed 2006-2019 MarketScan Commercial Claims and Encounters data. The longitudinal sample comprised females aged 15-45 with an OUD diagnosis at least once during the study period. We estimated fixed effects models that compared changes in outcomes between pregnant and nonpregnant females, in states with and without a PSUP, before and after PSUP implementation.

resultsOur analytical sample comprised 2,438,875 person-quarters from 164,538 unique females, of which 13% were pregnant at least once during the study period. We found that following the implementation of PSUPs funding targeted SUD treatment programs, the proportion of opioid overdoses decreased 45% and of any OUD medication increased 11%, with buprenorphine driving this increase (13%). The implementation of SUD treatment priority PSUPs was not associated with significant changes in outcomes. Following punitive PSUP implementation, the proportion receiving psychosocial services for SUD (12%) and methadone (30%) services decreased. In specifications that estimated the impact of criminalizing policies only, the strongest type of punitive PSUP, opioid overdoses increased 45%.

conclusionOur findings suggest that supportive approaches that enhance access to SUD treatment may effectively reduce adverse maternal outcomes associated with prenatal opioid use. In contrast, punitive approaches may have harmful effects. These findings support leading medical organizations' stance on PSUPs, which advocate for supportive policies that are centered on increased access to SUD treatment and safeguard against discrimination and stigmatization. Our findings also oppose punitive policies, as they may intensify marginalization of pregnant females with OUD seeking treatment.

Indexed as

BuprenorphineOpiate OverdoseOpioid-Related DisordersAnalgesics, OpioidFemaleHumansMethadoneOpiate Substitution TreatmentPolicyPregnancyAnalgesics, OpioidBuprenorphineMethadoneMaternal healthOpioid use disorderPregnancyPrenatal substance use policies

Identifiers

PMID35577664
PMCPMC9357143
OpenAlexW4280499373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.